Position in QGEN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,570,958
+$9,012,617 QoQ
Shares Held
313,960
+296.8% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Derivatives in QGEN
reported options exposure · as of Mar 31, 2024CallValue
$1,083,348
CallShares
25,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $925,783,255 across 15 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
492,580 | $246,959,908 | |
| 2 | A |
Agilent Technologies, Inc.
|
1,415,364 | $188,002,800 | |
| 3 | DHR |
Danaher Corp /De/
|
844,514 | $160,863,026 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
148,395 | $78,121,063 | |
| 5 | DGX |
Quest Diagnostics Inc
|
343,398 | $72,783,206 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
279,086 | $53,924,996 | |
| 7 | NTRA |
Natera, Inc.
|
161,079 | $43,724,894 | |
| 8 | GH |
Guardant Health, Inc.
|
156,236 | $23,440,087 |
All Filings in QGEN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,570,958 | 313,960 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,558,341 | 79,127 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $6,647,193 | 165,559 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,531,988 | 281,428 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,136,396 | 244,380 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $1,083,348 | 25,200 | Call | Sole | 2024-05-14 | |
| 2024-03-31 | $1,816,929 | 42,264 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $17,149,471 | 382,635 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $18,021,846 | 431,189 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $28,002,068 | 602,576 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $24,565,023 | 518,256 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $585,470 | 11,376 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $23,978,727 | 562,873 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,205,962 | 147,936 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,679,451 | 33,212 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $10,570,868 | 184,296 | Shares | Sole | 2022-02-10 | |
| 2021-06-30 | $2,207,707 | 44,218 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,971,317 | 39,232 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $2,508,372 | 46,510 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $9,942,265 | 225,042 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $552,048 | 12,859 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||